Ascentage Pharma management to participate in investor conferences in September.

Ascentage Pharma Group International will participate in three investor conferences in September 2025. The events include Citi's 2025 Biopharma Back to School, Cantor Global Healthcare Conference 2025, and H.C. Wainwright 27th Annual Global Investment Conference. The live webcast of the Citi and Cantor events can be accessed on the company's website.

Ascentage Pharma Group International has announced its participation in three prominent investor conferences in September 2025. The company will be present at Citi's 2025 Biopharma Back to School Conference, Cantor Global Healthcare Conference 2025, and H.C. Wainwright 27th Annual Global Investment Conference. The live webcasts of the Citi and Cantor events will be accessible on the company's investor relations website.

The Citi's 2025 Biopharma Back to School Conference will be held on September 2, 2025, at 4 p.m. ET in Boston, MA, featuring a fireside chat. The Cantor Global Healthcare Conference 2025 is scheduled for September 4, 2025, at 11:30 a.m. ET in New York, NY, also in the form of a fireside chat. The H.C. Wainwright 27th Annual Global Investment Conference will take place on September 9, 2025, at 9:30 a.m. ET in New York, NY, with a fireside chat format.

These conferences provide valuable opportunities for Ascentage Pharma Group International to engage with investors, discuss its pipeline of novel therapies, and share updates on its ongoing clinical trials. The company's participation underscores its commitment to transparency and investor relations.

References:
[1] https://ir.olema.com/news-releases/news-release-details/olema-oncology-participate-upcoming-investor-conferences-7
[2] https://en.coinotag.com/galaxy-multicoin-and-jump-may-seek-1-billion-solana-treasury-with-cantor-fitzgerald-as-lead-banker/